Lys 199 mutation of the human angiotensin type 1 receptor differentially affects the binding of surmountable and insurmountable non-peptide antagonists

Many slow dissociating (insurmountable) non-peptide angiotensin type 1 receptor (AT 1 ) antagonists contain, besides the acidic biphenyltetrazole substructure of losartan, a second acidic group to stabilise antagonist-receptor complexes. To investigate the involved basic amino-acids of the human AT...

Full description

Bibliographic Details
Main Authors: Frederik LP Fierens, Patrick ML Vanderheyden, Zsuzsanna Gáborik, Tam Le Minh, Jean-Paul De Backer, László Hunyady, Adriaan Ijzerman, Georges Vauquelin
Format: Article
Language:English
Published: SAGE Publications 2000-09-01
Series:Journal of the Renin-Angiotensin-Aldosterone System
Online Access:https://doi.org/10.3317/jraas.2000.044
_version_ 1797283678639882240
author Frederik LP Fierens
Patrick ML Vanderheyden
Zsuzsanna Gáborik
Tam Le Minh
Jean-Paul De Backer
László Hunyady
Adriaan Ijzerman
Georges Vauquelin
author_facet Frederik LP Fierens
Patrick ML Vanderheyden
Zsuzsanna Gáborik
Tam Le Minh
Jean-Paul De Backer
László Hunyady
Adriaan Ijzerman
Georges Vauquelin
author_sort Frederik LP Fierens
collection DOAJ
description Many slow dissociating (insurmountable) non-peptide angiotensin type 1 receptor (AT 1 ) antagonists contain, besides the acidic biphenyltetrazole substructure of losartan, a second acidic group to stabilise antagonist-receptor complexes. To investigate the involved basic amino-acids of the human AT 1 -receptor, wild-type and mutant receptors were transiently transfected in CHO-K1 cells and characterised by [ 3 H]candesartan binding. Lys 199 → Gln substitution decreased the affinity 45-fold for candesartan (95% insurmountable), 18-fold for EXP3174 (70% insurmountable), 10-fold for irbesartan (40% insurmountable) and 5-fold for losartan (surmountable). His 256 → Ala substitution had only minor effects. This suggests that Lys 199 is important for the tight binding of non-peptide antagonists.
first_indexed 2024-03-07T17:35:19Z
format Article
id doaj.art-a9ceec2575d64173805c80fd6cbf050a
institution Directory Open Access Journal
issn 1470-3203
language English
last_indexed 2024-03-07T17:35:19Z
publishDate 2000-09-01
publisher SAGE Publications
record_format Article
series Journal of the Renin-Angiotensin-Aldosterone System
spelling doaj.art-a9ceec2575d64173805c80fd6cbf050a2024-03-02T17:10:11ZengSAGE PublicationsJournal of the Renin-Angiotensin-Aldosterone System1470-32032000-09-01110.3317/jraas.2000.044Lys 199 mutation of the human angiotensin type 1 receptor differentially affects the binding of surmountable and insurmountable non-peptide antagonistsFrederik LP FierensPatrick ML VanderheydenZsuzsanna GáborikTam Le MinhJean-Paul De BackerLászló HunyadyAdriaan IjzermanGeorges VauquelinMany slow dissociating (insurmountable) non-peptide angiotensin type 1 receptor (AT 1 ) antagonists contain, besides the acidic biphenyltetrazole substructure of losartan, a second acidic group to stabilise antagonist-receptor complexes. To investigate the involved basic amino-acids of the human AT 1 -receptor, wild-type and mutant receptors were transiently transfected in CHO-K1 cells and characterised by [ 3 H]candesartan binding. Lys 199 → Gln substitution decreased the affinity 45-fold for candesartan (95% insurmountable), 18-fold for EXP3174 (70% insurmountable), 10-fold for irbesartan (40% insurmountable) and 5-fold for losartan (surmountable). His 256 → Ala substitution had only minor effects. This suggests that Lys 199 is important for the tight binding of non-peptide antagonists.https://doi.org/10.3317/jraas.2000.044
spellingShingle Frederik LP Fierens
Patrick ML Vanderheyden
Zsuzsanna Gáborik
Tam Le Minh
Jean-Paul De Backer
László Hunyady
Adriaan Ijzerman
Georges Vauquelin
Lys 199 mutation of the human angiotensin type 1 receptor differentially affects the binding of surmountable and insurmountable non-peptide antagonists
Journal of the Renin-Angiotensin-Aldosterone System
title Lys 199 mutation of the human angiotensin type 1 receptor differentially affects the binding of surmountable and insurmountable non-peptide antagonists
title_full Lys 199 mutation of the human angiotensin type 1 receptor differentially affects the binding of surmountable and insurmountable non-peptide antagonists
title_fullStr Lys 199 mutation of the human angiotensin type 1 receptor differentially affects the binding of surmountable and insurmountable non-peptide antagonists
title_full_unstemmed Lys 199 mutation of the human angiotensin type 1 receptor differentially affects the binding of surmountable and insurmountable non-peptide antagonists
title_short Lys 199 mutation of the human angiotensin type 1 receptor differentially affects the binding of surmountable and insurmountable non-peptide antagonists
title_sort lys 199 mutation of the human angiotensin type 1 receptor differentially affects the binding of surmountable and insurmountable non peptide antagonists
url https://doi.org/10.3317/jraas.2000.044
work_keys_str_mv AT frederiklpfierens lys199mutationofthehumanangiotensintype1receptordifferentiallyaffectsthebindingofsurmountableandinsurmountablenonpeptideantagonists
AT patrickmlvanderheyden lys199mutationofthehumanangiotensintype1receptordifferentiallyaffectsthebindingofsurmountableandinsurmountablenonpeptideantagonists
AT zsuzsannagaborik lys199mutationofthehumanangiotensintype1receptordifferentiallyaffectsthebindingofsurmountableandinsurmountablenonpeptideantagonists
AT tamleminh lys199mutationofthehumanangiotensintype1receptordifferentiallyaffectsthebindingofsurmountableandinsurmountablenonpeptideantagonists
AT jeanpauldebacker lys199mutationofthehumanangiotensintype1receptordifferentiallyaffectsthebindingofsurmountableandinsurmountablenonpeptideantagonists
AT laszlohunyady lys199mutationofthehumanangiotensintype1receptordifferentiallyaffectsthebindingofsurmountableandinsurmountablenonpeptideantagonists
AT adriaanijzerman lys199mutationofthehumanangiotensintype1receptordifferentiallyaffectsthebindingofsurmountableandinsurmountablenonpeptideantagonists
AT georgesvauquelin lys199mutationofthehumanangiotensintype1receptordifferentiallyaffectsthebindingofsurmountableandinsurmountablenonpeptideantagonists